Literature DB >> 8016133

A stereochemical approach to pyranose ring flexibility: its implications for the conformation of dermatan sulfate.

G Venkataraman1, V Sasisekharan, C L Cooney, R Langer, R Sasisekharan.   

Abstract

Glycosaminoglycans, such as heparin, heparan sulfate, and dermatan sulfate, are characterized by a disaccharide repeating unit of a uronate and a hexosamine and are increasingly understood to be important physiologically as soluble components of the extracellular matrix. The secondary structure of this class of acidic polysaccharides is believed to play a key role in determining the wide range of biological specificities. Central to the structural diversity of the glycosaminoglycans is the experimentally documented conformational flexibility of the iduronate residue. Here, we outline an approach to explore the iduronate conformational flexibility by imposing stereochemical criteria of nonbonded contact distances. By performing a complete search of all possible torsions that define the iduronate ring geometry, we eliminate any prior bias with regard to minimum energy conformers. The approach led to alternative feasible conformers for the iduronate ring that are stereochemically satisfactory and are consistent with the available physico-chemical data.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016133      PMCID: PMC44160          DOI: 10.1073/pnas.91.13.6171

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

Review 1.  Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes.

Authors:  R L Jackson; S J Busch; A D Cardin
Journal:  Physiol Rev       Date:  1991-04       Impact factor: 37.312

Review 2.  Proteoglycans as modulators of growth factor activities.

Authors:  E Ruoslahti; Y Yamaguchi
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

Review 3.  Structure of heparan sulfate and dermatan sulfate.

Authors:  H E Conrad
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

Review 4.  Proteoglycans: structures and interactions.

Authors:  L Kjellén; U Lindahl
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

5.  Human lymphocytopathic retroviruses (HLRV)?

Authors:  J W Shields
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

6.  Controversial glycosaminoglycan conformations.

Authors:  B Casu; J Choay; D R Ferro; G Gatti; J C Jacquinet; M Petitou; A Provasoli; M Ragazzi; P Sinay; G Torri
Journal:  Nature       Date:  1986 Jul 17-23       Impact factor: 49.962

Review 7.  Conformation of polypeptides and proteins.

Authors:  G N Ramachandran; V Sasisekharan
Journal:  Adv Protein Chem       Date:  1968

8.  N.m.r. and molecular-modelling studies of the solution conformation of heparin.

Authors:  B Mulloy; M J Forster; C Jones; D B Davies
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

9.  Dermatan sulfate: molecular conformations and interactions in the condensed state.

Authors:  A K Mitra; S Arnott; E D Atkins; D H Isaac
Journal:  J Mol Biol       Date:  1983-10-05       Impact factor: 5.469

10.  Solid-state 13C NMR and X-ray diffraction of dermatan sulfate.

Authors:  W T Winter; M G Taylor; E S Stevens; E R Morris; D A Rees
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

View more
  12 in total

1.  The force-driven conformations of heparin studied with single molecule force microscopy.

Authors:  Piotr E Marszalek; Andres F Oberhauser; Hongbin Li; Julio M Fernandez
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

2.  Solution dynamics of the 1,2,3,4,6-penta-O-acetyl-alpha-D-idopyranose ring.

Authors:  D A Horita; P J Hajduk; L E Lerner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Perspective on computational simulations of glycosaminoglycans.

Authors:  Balaji Nagarajan; Nehru Viji Sankaranarayanan; Umesh R Desai
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2018-09-10

4.  Spatial distribution and orientation of dermatan sulfate in human medial collateral ligament.

Authors:  Heath B Henninger; Steve A Maas; Clayton J Underwood; Ross T Whitaker; Jeffrey A Weiss
Journal:  J Struct Biol       Date:  2006-10-21       Impact factor: 2.867

5.  Structural specificity of heparin binding in the fibroblast growth factor family of proteins.

Authors:  Rahul Raman; Ganesh Venkataraman; Steffen Ernst; V Sasisekharan; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  Tandem mass spectrometric strategies for determination of sulfation positions and uronic acid epimerization in chondroitin sulfate oligosaccharides.

Authors:  Joseph Zaia; Xue-Qing Li; Shiu-Yung Chan; Catherine E Costello
Journal:  J Am Soc Mass Spectrom       Date:  2003-11       Impact factor: 3.109

7.  Understanding Dermatan Sulfate-Heparin Cofactor II Interaction through Virtual Library Screening.

Authors:  Arjun Raghuraman; Philip D Mosier; Umesh R Desai
Journal:  ACS Med Chem Lett       Date:  2010-06-14       Impact factor: 4.345

8.  Transversely isotropic distribution of sulfated glycosaminoglycans in human medial collateral ligament: a quantitative analysis.

Authors:  Heath B Henninger; Steve A Maas; Jonathan H Shepherd; Sarang Joshi; Jeffrey A Weiss
Journal:  J Struct Biol       Date:  2008-12-24       Impact factor: 2.867

9.  The structure of chondroitin B lyase complexed with glycosaminoglycan oligosaccharides unravels a calcium-dependent catalytic machinery.

Authors:  Gurvan Michel; Kevin Pojasek; Yunge Li; Traian Sulea; Robert J Linhardt; Rahul Raman; Vikas Prabhakar; Ram Sasisekharan; Miroslaw Cygler
Journal:  J Biol Chem       Date:  2004-05-21       Impact factor: 5.157

10.  FGF-2 release from the lens capsule by MMP-2 maintains lens epithelial cell viability.

Authors:  Frederique M D Tholozan; Christopher Gribbon; Zheng Li; Martin W Goldberg; Alan R Prescott; Norman McKie; Roy A Quinlan
Journal:  Mol Biol Cell       Date:  2007-08-15       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.